Stevanato Group S.p.A.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, …
Medical - Instruments & Supplies
IT, Piombino Dese [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 28.28 | 1.92 | 1.50 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -1.77 | 4.09 | 4.17 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 17.28 | 5.01 | 4.27 | |
| Cash | 169.13 | 0.71 | 0.27 | |
| Capex | -27.50 | -0.39 | -0.30 | |
| Free Cash Flow | 56.62 | -0.12 | -0.27 | |
| Revenue | -24.14 | 0.89 | 1.18 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -17.92 | 0.25 | 0.30 | |
| Operating Margin | -46.71 | 0.10 | 0.19 | |
| ROA | -61.06 | < 0.005 | 0.02 | |
| ROE | -64.59 | 0.01 | 0.04 | |
| ROIC | -65.40 | 0.01 | 0.03 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of STVN is permitted for members.
5
Growth
The "Growth Entry" for the Focus of STVN is permitted for members.
6
Leverage & Liquidity